Literature DB >> 3654947

Immunization of elderly people with two doses of influenza vaccine.

P A Gross1, M E Weksler, G V Quinnan, R G Douglas, P F Gaerlan, C R Denning.   

Abstract

A total of 104 elderly patients were immunized with one or two doses of the commercial 1985-1986 inactivated influenza vaccine formulation. Two types of vaccines (split virus [SV] vaccine and whole virus [WV] vaccine) and one or two doses 1 month apart were given. No difference in local or systemic reactions was noted among the four groups. The reciprocal geometric mean hemagglutination inhibition antibody titers against influenza A/Philippines/82 (H3N2) after one or two doses were: 78 for SV vaccine (one dose), 65 for SV vaccine (two doses), 55 for WV vaccine (one dose), and 51 for WV vaccine (two doses). Similar nonsignificant differences were observed for the other two antigens contained in the vaccine. The percentage with a hemagglutination inhibition titer of greater than or equal to 1:40 also did not differ after one or two doses. We then compared the postvaccination hemagglutination inhibition titers in young and old patients from previous studies in which apparent differences had appeared. We retested all sera simultaneously on the same day with the same reagents. No significant differences were apparent among age groups. In summary, the humoral immune response to inactivated influenza vaccine in healthy ambulatory elderly patients who have been previously immunized may not differ significantly from that of children and young adults. A booster dose 1 month after the first dose does not enhance immune responses in the elderly.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654947      PMCID: PMC269323          DOI: 10.1128/jcm.25.9.1763-1765.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size.

Authors:  A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976.

Authors:  B J Feery; M G Evered; E I Morrison
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

3.  Failure of inactivated influenza vaccine to protect an aged population.

Authors:  D J D'Alessio; P M Cox; E C Dick
Journal:  JAMA       Date:  1969-10-20       Impact factor: 56.272

4.  Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines.

Authors:  M W Brandriss; R F Betts; U Mathur; R G Douglas
Journal:  Am Rev Respir Dis       Date:  1981-12

5.  Influenza vaccine in unprimed children: improved immunogenicity with few reactions following one high dose of split-product vaccine.

Authors:  P A Gross; F A Ennis; G R Noble; P F Gaerlan; W J Davis; C E Denning
Journal:  J Pediatr       Date:  1980-07       Impact factor: 4.406

6.  Influenza vaccination and mortality from bronchopneumonia in the elderly.

Authors:  C H Howells; C K Vesselinova-Jenkins; A D Evans; J James
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

7.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  7 in total
  18 in total

1.  Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.

Authors:  A M Iorio; T Zei; M Neri; L Campitelli; M R Castrucci; I Donatelli
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

2.  Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.

Authors:  Yi-Chun Lai; Kuen-Cheh Yang; Szu-Min Hsieh; Chien-An Yao; Long-Teng Lee; Kuo-Chin Huang
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

3.  Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Authors:  Hiroko Matsumoto; Satoko Ohfuji; Kenji Watanabe; Hirokazu Yamagami; Wakaba Fukushima; Kazuhiro Maeda; Noriko Kamata; Mitsue Sogawa; Masatsugu Shiba; Tetsuya Tanigawa; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Yoshio Hirota; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2015-02-12       Impact factor: 7.527

4.  Natural killer cell cytotoxicity in elderly humans after influenza immunization.

Authors:  J Kutza; P Gross; D Kaye; D M Murasko
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2011-10-14

6.  Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-08-31

7.  STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2012-08-01

8.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

9.  [Perimyocarditis in influenza A virus infection].

Authors:  D Franzen; T Mertens; T Waidner; J Kruppenbächer; H W Höpp; H H Hilger
Journal:  Klin Wochenschr       Date:  1991-06-18

Review 10.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.